Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

6.67
Delayed Data
As of Aug 28
 +0.15 / +2.30%
Today’s Change
4.85
Today|||52-Week Range
9.60
-23.95%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close6.52
Today’s open6.49
Day’s range6.49 - 6.70
Volume298,537
Average volume (3 months)530,515
Market cap$420.7M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+55.25%
Earnings growth (this year)-80.25%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+489.46%
P/E ratioNM
Price/Sales11.39
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
IGIGI Laboratories Inc+0.45+5.88%
RGLSRegulus Therapeutics...+0.79+10.56%
MRTXMirati Therapeutics ...+1.17+4.59%
NEOSNeos Therapeutics In...+0.50+1.88%
Data as of 4:07pm ET, 08/28/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$46.9M
Annual profit (last year)-$49.3M
Net profit margin-105.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald W. Barrett
Chief Operating Officer &
Executive Vice President
Vincent J. Angotti
Corporate headquarters
Santa Clara, California

Forecasts

Partner Offers